1. Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems Shang, Enyuan; Zhang, Yiru; Shu, Chang; Ishida, Chiaki Tsuge; Bianchetti, Elena; Westhoff, Mike-Andrew; Karpel-Massler, Georg; Siegelin, Markus D. 2018 Articles Glioblastoma multiformeTumors--TreatmentNeurogliaCell deathCancer--Treatment
2. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy Ströbele, Stephanie; Schneider, Matthias; Schneele, Lukas; Siegelin, Markus D.; Nonnenmacher, Lisa; Zhou, Shaoxia; Karpel-Massler, Georg; Westhoff, Mike-Andrew; Halatsch, Marc-Eric; Debatin, Klaus-Michael 2015 Articles Glioblastoma multiformeCellular signal transductionOncologyCytology
3. A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy Westhoff, Mike-Andrew; Karpel-Massler, Georg; Brühl, Oliver; Enzenmüller, Stefanie; La Ferla-Brühl, Katia; Siegelin, Markus D.; Nonnenmacher, Lisa; Debatin, Klaus-Michael 2014 Articles OncologyNeurosciences
4. PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma Karpel-Massler, Georg; Pareja, Fresia; Aime, Pascaline; Shu, Chang; Chau, Lily; Westhoff, Mike-Andrew; Halatsch, Marc-Eric; Crary, John F.; Canoll, Peter D.; Siegelin, Markus D. 2014 Articles ApoptosisNAD-ADP-ribosyltransferaseCancer--Treatment--ResearchGlioblastoma multiformePathologyCytologyOncology